Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biopharma’s Coronavirus ‘Self-Isolating’: Companies Cancel Investor Meetings, Cut Back Travel

Vertex and Seattle Genetics Pull Out Of Conference

Executive Summary

As the coronavirus spreads beyond China, biopharma companies are taking precautions, with some more wary than others.

You may also be interested in...



How COVID-19 Defined 2020 For Biopharma

Development of vaccines usually takes years, but drug makers whittled the process down to a matter of months amid a concerted response to a global health threat.

Biogen Linked To More Coronavirus Cases In Boston

Company has instructed employees and contractors to self isolate to prevent further spread of COVID-19.

A Rebuke To Pharma Globalization? Coronavirus Shows Value Of Regional Supply Chain Redundancy

As virus impedes China’s API production and spreads to other global manufacturing centers, need for robust supply chain alternatives becomes clear.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC141767

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel